About ATP-dependent RNA helicase DDX19A
ATP-dependent RNA helicase DDX19A (DDX19A) is a protein
from Homo sapiens identified by UniProt accession
Q9NUU7, 478 residues long.
MolForge cross-references it against 0 known binders and
28 disease associations.
Target properties
| Protein name | ATP-dependent RNA helicase DDX19A |
| UniProt accession | Q9NUU7 |
| Gene | DDX19A |
| Organism | Homo sapiens |
| Length | 478 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (28)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.43
- Parkinson disease · score 0.24
- multiple sclerosis · score 0.24
- Alzheimer disease · score 0.24
- lysosomal storage disease · score 0.24
- haptoglobin measurement · score 0.20
- gastric carcinoma · score 0.15
- body height · score 0.09
- body mass index · score 0.08
- blood protein measurement · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NUU7-F1 | alphafold | PREDICTED | 80.69 | — |
Amino-acid sequence (478 residues)
MATDSWALAV DEQEAAVKSM TNLQIKEEKV KADTNGIIKT STTAEKTDEE EKEDRAAQSL LNKLIRSNLV DNTNQVEVLQ RDPNSPLYSV KSFEELRLKP QLLQGVYAMG FNRPSKIQEN ALPMMLAEPP QNLIAQSQSG TGKTAAFVLA MLSRVEPSDR YPQCLCLSPT YELALQTGKV IEQMGKFYPE LKLAYAVRGN KLERGQKISE QIVIGTPGTV LDWCSKLKFI DPKKIKVFVL DEADVMIATQ GHQDQSIRIQ RMLPRNCQML LFSATFEDSV WKFAQKVVPD PNVIKLKREE ETLDTIKQYY VLCSSRDEKF QALCNLYGAI TIAQAMIFCH TRKTASWLAA ELSKEGHQVA LLSGEMMVEQ RAAVIERFRE GKEKVLVTTN VCARGIDVEQ VSVVINFDLP VDKDGNPDNE TYLHRIGRTG RFGKRGLAVN MVDSKHSMNI LNRIQEHFNK KIERLDTDDL DEIEKIAN
Explore ATP-dependent RNA helicase DDX19A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets